Necrotizing soft tissue invasive aspergillosis in a cancer patient treated with immunosupressants due to checkpoint inhibitor-induced hepatitis - 05/02/20
Doi : 10.1016/j.jinf.2019.10.022
Alexandre E. Malek a, b, ⁎ 
, Mahnaz Taremi a, Amy Spallone a, c, Julio J. Alvarez-Cardona a, Dimitrios P. Kontoyiannis a
, Mahnaz Taremi a, Amy Spallone a, c, Julio J. Alvarez-Cardona a, Dimitrios P. Kontoyiannis a a Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
b Department of Internal Medicine, Division of Infectious Diseases, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA
c Department of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA
⁎Corresponding author at: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.at: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX,USA
Keywords : Aspergillus, Fungal myositis, Checkpoint inhibitors, Immune related adverse events, Corticosteroids
Le texte complet de cet article est disponible en PDF.
© 2019
Publié par Elsevier Masson SAS.
Vol 80 - N° 2
P. 232-254 - février 2020 Retour au numéro
Article précédent
- Higher sustained virological response rates at 12 weeks in HIV-HCV co-infection; a tertiary centre experience
- L Carvalho, S Pillai, E Daniels, P Sellers, R Whyte, L Eveson, M Foxton, M Nelson
- Metagenomic analysis reveals the abundance and diversity of ARGs in children's respiratory tract microbiomes
- Fei Liu, Yanan Wang, George Fu Gao, Baoli Zhu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?